STABLE SURFACE EXPRESSION OF INVARIANT CHAIN PREVENTS PEPTIDE PRESENTATION BY HLA-DR

被引:102
|
作者
ROCHE, PA
TELETSKI, CL
KARP, DR
PINET, V
BAKKE, O
LONG, EO
机构
[1] NIAID,IMMUNOGENET LAB,TWINBROOK II FACIL,12441 PARKLAWN DR,ROCKVILLE,MD 20852
[2] UNIV OSLO,DEPT BIOL,N-0316 OSLO,NORWAY
来源
EMBO JOURNAL | 1992年 / 11卷 / 08期
关键词
ANTIGEN PRESENTATION; ENDOSOME; HLA-DR; INTRACELLULAR TRAFFIC; INVARIANT CHAIN;
D O I
10.1002/j.1460-2075.1992.tb05351.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Class II major histocompatibility complex (MHC) molecules are cell surface glycoproteins that bind and present immunogenic peptides to T cells. Intracellularly, class II molecules associate with a polypeptide referred to as the invariant (Ii) chain. Ii is proteolytically degraded and dissociates from the class II complex prior to cell surface expression of the mature class II alpha-beta-heterodimer. Using human fibroblasts transfected with HLA-DR1 and Ii cDNAs, we now demonstrate that truncation of the cytoplasmic domain of Ii results in the failure of Ii to dissociate from the alpha-beta-Ii complex and leads to stable expression of class II alpha-beta-Ii complexes on the cell surface. Furthermore, biochemical analysis and peptide presentation assays demonstrated that transfectants with stable surface alpha-beta-Ii complexes expressed very few free alpha-beta heterodimers at the surface and were very inefficient in their ability to present immunogenic peptides to T cells. These results support the hypothesis that the cytoplasmic domain of Ii is responsible for endosomal targeting of alpha-beta-Ii and directly demonstrate that association with Ii interferes with the antigen presentation function of class II molecules.
引用
收藏
页码:2841 / 2847
页数:7
相关论文
共 50 条
  • [1] INVARIANT CHAIN PREVENTS THE HLA-DR-RESTRICTED PRESENTATION OF A CYTOSOLIC PEPTIDE
    LONG, EO
    LAVAUTE, T
    PINET, V
    JARAQUEMADA, D
    JOURNAL OF IMMUNOLOGY, 1994, 153 (04): : 1487 - 1494
  • [2] ASSOCIATION WITH THE INVARIANT CHAIN INHIBITS PEPTIDE BINDING TO HLA-DR
    ROCHE, PA
    CRESSWELL, P
    FASEB JOURNAL, 1991, 5 (06): : A1460 - A1460
  • [3] HLA-DR INVARIANT CHAIN EXPRESSION DURING ACTIVATION AND DIFFERENTIATION OF LYMPHOCYTES
    HOLTER, W
    MAJDIC, O
    LISZKA, K
    STOCKINGER, H
    KOLLER, U
    KNAPP, W
    IMMUNOBIOLOGY, 1984, 168 (1-2) : 3 - 3
  • [4] HLA-DR INVARIANT CHAIN EXPRESSION DURING ACTIVATION AND DIFFERENTIATION OF LYMPHOCYTES
    HOLTER, W
    MAJDIC, O
    LISZKA, K
    STOCKINGER, H
    KOLLER, U
    KNAPP, W
    IMMUNOBIOLOGY, 1984, 167 (1-3) : 234 - 234
  • [5] INVARIANT CHAIN ASSOCIATION WITH HLA-DR MOLECULES INHIBITS IMMUNOGENIC PEPTIDE BINDING
    ROCHE, PA
    CRESSWELL, P
    NATURE, 1990, 345 (6276) : 615 - 618
  • [6] NON-CO-ORDINATE EXPRESSION OF HLA-DR ANTIGENS AND INVARIANT CHAIN
    MOMBURG, F
    MOLLER, P
    IMMUNOLOGY, 1988, 63 (03) : 551 - 553
  • [7] REGULATION OF HLA-DR SURFACE EXPRESSION
    COTNER, T
    PIOUS, D
    FASEB JOURNAL, 1988, 2 (06): : A1829 - A1829
  • [8] INVARIANT CHAIN INFLUENCES POSTTRANSLATIONAL PROCESSING OF HLA-DR MOLECULES
    SCHAIFF, WT
    HRUSKA, KA
    BONO, C
    SHUMAN, S
    SCHWARTZ, BD
    JOURNAL OF IMMUNOLOGY, 1991, 147 (02): : 603 - 608
  • [9] BIOSYNTHESIS AND GLYCOSYLATION OF THE INVARIANT CHAIN ASSOCIATED WITH HLA-DR ANTIGENS
    MACHAMER, CE
    CRESSWELL, P
    JOURNAL OF IMMUNOLOGY, 1982, 129 (06): : 2564 - 2569
  • [10] HLA-DM can partially replace the invariant chain for HLA-DR transport and surface expression in transfected endocrine epithelial cells
    Serradell, L
    Muntasell, A
    Catálfamo, M
    Martí, M
    Costa, M
    de Préval, C
    Jaraquemada, D
    TISSUE ANTIGENS, 1999, 53 (05): : 447 - 458